A year-long management dispute within the Hanmi Pharmaceutical Group family is nearing resolution. The conflict began in ...

Hanmi Pharmaceutical CEO Park Jae-hyun at the extraordinary shareholder meeting held in Songpa District, southern Seoul, on Thursday. [YONHAP] Efforts to seize the management rights of Hanmi ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Flu surge boosts demand for medications and diagnostics in South Korea Flu season drives sharp rise in pharmaceutical sales ...

The management rights dispute of Hanmi Pharmaceutical Group, which has been ongoing for nearly a year between the founder's family, including daughters and brothers, has reached a new phase.

SEOUL, South Korea, Nov. 24, 2024 /PRNewswire/ -- The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SEOUL, South Korea, Nov. 24, 2024 /PRNewswire/ -- The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi ...

Merck & Co. Inc. has turned to Asia for a second time to get into the GLP-1 market, this time to Shanghai-based Hansoh Pharmaceutical Group Co. Ltd. for its investigational preclinical oral ...